Management of Patients with Hematological Malignancies Undergoing Coronary Artery Bypass Grafting
We describe three cases with hematological malignancies namely chronic myelogenous leukemia, acute promyelocytic leukemia and chronic lymphocytic leukemia presenting for coronary artery bypass grafting (CABG).